These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13730722)

  • 1. [Severe osteoporosis of the spine treated with high doses of Durabolin].
    OLESEN V
    Ugeskr Laeger; 1960 Nov; 122():1655-7. PubMed ID: 13730722
    [No Abstract]   [Full Text] [Related]  

  • 2. [Durabolin in bone pathology].
    DREYFUS P
    Gaz Med Fr; 1961 Nov; 68():2579-81. PubMed ID: 13887846
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteoporosis treatment with nandrolone phenpropionate.
    BANGHART HE
    Pa Med J; 1961 Aug; 64():984-6. PubMed ID: 13686583
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations on the treatment of some forms of endocrine osteoporosis with anabolic steroids].
    MOLINATTI GM; CAMANNI F; OLIVETTI M
    Minerva Med; 1961 Feb; 52():367-72. PubMed ID: 13771826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the clinical use of 4-chlortestosterone acetate in the treatment of dysendocrine osteoporosis].
    POZZI L; SALVI V
    Arch Ortop; 1959; 72():1635-41. PubMed ID: 14434611
    [No Abstract]   [Full Text] [Related]  

  • 6. [First results of the treatment of cortisone osteoporosis with the combination of a non-virilizing synthetic anabolic drug. 17-ethyl-19-nortestosterone, and desoxyribonucleic acid].
    ISEMEIN L; TABAU R; FOURNIER AM; VIGNOLI R
    Rev Rhum Mal Osteoartic; 1960 Dec; 27():547-58. PubMed ID: 13717970
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the theoretical bases of the therapy of osteoporotic syndromes with a combination of anabolic steroids, adenesine triphosphoric acid and vitamin C].
    SANTACROCE A; PIPINO F
    Minerva Med; 1961 Apr; 52():1352-4. PubMed ID: 13746316
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
    ZARA M; LUMBROSO A
    Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the metabolic effects of an anabolic drug with a steroid structure: methandrostenolone].
    ROMANI JD; KELLER A
    Ann Endocrinol (Paris); 1961; 22():65-81. PubMed ID: 13742997
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.
    Spry NA; Galvão DA; Davies R; La Bianca S; Joseph D; Davidson A; Prince R
    BJU Int; 2009 Sep; 104(6):806-12. PubMed ID: 19281463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc].
    Kawate H; Takayanagi R
    Clin Calcium; 2010 May; 20(5):744-51. PubMed ID: 20445286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatments by calcium and sex hormones on vertebral fracturing in osteoporosis.
    Almustafa M; Doyle FH; Gutteridge DH; Hand DJ; Davis TM; Spinks TJ; Freemantle C; Joplin GF
    Q J Med; 1992 Apr; 83(300):283-94. PubMed ID: 1321457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility.
    Kacker R; Conners W; Zade J; Morgentaler A
    J Urol; 2014 Apr; 191(4):1072-6. PubMed ID: 24161998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the use of Durabolin on diphtheria patients].
    MINAMISAWA Y; SAITO M
    Nihon Densenbyo Gakkai Zasshi; 1962 May; 36():39-42. PubMed ID: 14474273
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered bioreactivity and limited osteoconductivity of calcium sulfate-based bone cements in the osteoporotic rat spine.
    Wang ML; Massie J; Allen RT; Lee YP; Kim CW
    Spine J; 2008; 8(2):340-50. PubMed ID: 17983844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical use of deca-durabolin for carcinoma patients].
    REIFFENSTUHL G
    Med Klin; 1961 May; 56():847-9. PubMed ID: 13740527
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of durabolin on weight increase in children].
    JONXIS JH
    Ned Tijdschr Geneeskd; 1957 Mar; 101(9):389-92. PubMed ID: 13430853
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.